Literature DB >> 23429057

Structural and immunological correlations between the variable blocks of the VAR2CSA domain DBL6ε from two Plasmodium falciparum parasite lines.

Stéphane Gangnard1, Cyril Badaut, Stéphanie Ramboarina, Bruno Baron, Tarik Ramdani, Benoît Gamain, Philippe Deloron, Anita Lewit-Bentley, Graham A Bentley.   

Abstract

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), a family of adhesins of the falciparum species of the malaria parasite, is exposed on the surface of the infected erythrocyte. In general, only one PfEMP1 variant is expressed at a time but switching between variants occurs, changing both host-cell receptor specificity and serotype. The PfEMP1 variant VAR2CSA causes sequestration of infected erythrocytes in the intervillous spaces of the placenta via the glycosaminoglycan chondroitin sulfate A. This leads to pregnancy-associated malaria, which has severe consequences for the fetus and mother. The extracellular region of VAR2CSA comprises six DBL (Duffy-binding-like) domains and a single CIDR (cysteine-rich inter-domain region) domain. The C-terminal domain DBL6ε, the most polymorphic domain of VAR2CSA, has seven regions of high variability termed variable blocks (VBs). Here we have determined the crystal structure of DBL6ε from the FCR3 parasite line and have compared it with the previously determined structure of that from the 3D7 line. We found significant differences particularly in the N-terminal region, which contains the first VB (VB1). Although DBL6ε is the most variable VAR2CSA domain, DBL6ε-FCR3 and DBL6ε-3D7 react with IgG purified from immune sera of pregnant women. Furthermore, IgG purified on one domain cross-reacts with the other, confirming the presence of cross-reactive epitopes. We also examined reactivity of immune sera to the four least variable VB (VB1, VB2, VB4 and VB5) using peptides with the consensus sequence closest, in turn, to the FCR3 or 3D7 domain. These results provide new molecular insights into immune escape by parasites expressing the VAR2CSA variant.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429057     DOI: 10.1016/j.jmb.2013.02.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.

Authors:  Rui Ma; Tengfei Lian; Rick Huang; Jonathan P Renn; Jennifer D Petersen; Joshua Zimmerberg; Patrick E Duffy; Niraj H Tolia
Journal:  Nat Microbiol       Date:  2021-01-15       Impact factor: 17.745

Review 2.  Paths to a malaria vaccine illuminated by parasite genomics.

Authors:  David J Conway
Journal:  Trends Genet       Date:  2015-01-22       Impact factor: 11.639

3.  Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade.

Authors:  Jaymin C Patel; Nicholas J Hathaway; Christian M Parobek; Kyaw L Thwai; Mwayiwawo Madanitsa; Carole Khairallah; Linda Kalilani-Phiri; Victor Mwapasa; Achille Massougbodji; Nadine Fievet; Jeffery A Bailey; Feiko O Ter Kuile; Philippe Deloron; Stephanie M Engel; Steve M Taylor; Jonathan J Juliano; Nicaise Tuikue Ndam; Steven R Meshnick
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

4.  Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens.

Authors:  Ana Maria Fonseca; Llorenç Quinto; Alfons Jiménez; Raquel González; Azucena Bardají; Sonia Maculuve; Carlota Dobaño; Maria Rupérez; Anifa Vala; John J Aponte; Esperanza Sevene; Eusebio Macete; Clara Menéndez; Alfredo Mayor
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

5.  Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains.

Authors:  Justin Y A Doritchamou; Robert Morrison; Jonathan P Renn; Jose Ribeiro; Junhui Duan; Michal Fried; Patrick E Duffy
Journal:  Commun Biol       Date:  2019-12-06

Review 6.  VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria.

Authors:  Alice Tomlinson; Jean-Philippe Semblat; Benoît Gamain; Arnaud Chêne
Journal:  Front Immunol       Date:  2021-02-09       Impact factor: 7.561

7.  Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding.

Authors:  Kaituo Wang; Robert Dagil; Thomas Lavstsen; Sandeep K Misra; Charlotte B Spliid; Yong Wang; Tobias Gustavsson; Daniel R Sandoval; Elena Ethel Vidal-Calvo; Swati Choudhary; Mette Ø Agerbaek; Kresten Lindorff-Larsen; Morten A Nielsen; Thor G Theander; Joshua S Sharp; Thomas Mandel Clausen; Pontus Gourdon; Ali Salanti
Journal:  Nat Commun       Date:  2021-05-19       Impact factor: 14.919

8.  Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.

Authors:  Stéphane Gangnard; Anita Lewit-Bentley; Sébastien Dechavanne; Anand Srivastava; Faroudja Amirat; Graham A Bentley; Benoît Gamain
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

9.  Using the PfEMP1 head structure binding motif to deal a blow at severe malaria.

Authors:  Manuel E Patarroyo; Martha Patricia Alba; Hernando Curtidor; Magnolia Vanegas; Hannia Almonacid; Manuel A Patarroyo
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

10.  Molecular architecture and domain arrangement of the placental malaria protein VAR2CSA suggests a model for carbohydrate binding.

Authors:  Maria C Bewley; Lovely Gautam; Mashanipalya G Jagadeeshaprasad; D Channe Gowda; John M Flanagan
Journal:  J Biol Chem       Date:  2020-10-29       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.